-
Determination of Free 25(OH)D Concentrations and Their Relationships to Total 25(OH)D in Multiple Clinical Populations. J Clin Endocrinol Metab. 2018 09 01; 103(9):3278-3288.
Schwartz JB, Gallagher JC, Jorde R, Berg V, Walsh J, Eastell R, Evans AL, Bowles S, Naylor KE, Jones KS, Schoenmakers I, Holick M, Orwoll E, Nielson C, Kaufmann M, Jones G, Bouillon R, Lai J, Verotta D, Bikle D. PMID: 29955795; PMCID: PMC6126881.
View in:
PubMed Mentions:
47 Fields:
Translation:
Humans
-
Determination of Tobramycin in M9 Medium by LC-MS/MS: Signal Enhancement by Trichloroacetic Acid. J Anal Methods Chem. 2018; 2018:7965124.
Huang L, Haagensen JAJ, Verotta D, Cheah V, Spormann AM, Aweeka F, Yang K. PMID: 29854560; PMCID: PMC5944200.
View in:
PubMed Mentions:
-
Mathematical Modeling of Biofilm Structures Using COMSTAT Data. Comput Math Methods Med. 2017; 2017:7246286.
Verotta D, Haagensen J, Spormann AM, Yang K. PMID: 29422943; PMCID: PMC5751404.
View in:
PubMed Mentions:
1 Fields:
Translation:
Cells
-
Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms. J Antimicrob Chemother. 2017 Dec 01; 72(12):3357-3365.
Haagensen J, Verotta D, Huang L, Engel J, Spormann AM, Yang K. PMID: 28961810; PMCID: PMC5890705.
View in:
PubMed Mentions:
16 Fields:
Translation:
Cells
-
New in vitro model to study the effect of human simulated antibiotic concentrations on bacterial biofilms. Antimicrob Agents Chemother. 2015 Jul; 59(7):4074-81.
Haagensen JA, Verotta D, Huang L, Spormann A, Yang K. PMID: 25918138; PMCID: PMC4468651.
View in:
PubMed Mentions:
10 Fields:
Translation:
HumansCells
-
Determination of meropenem in bacterial media by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Jun 15; 961:71-6.
Huang L, Haagensen J, Verotta D, Lizak P, Aweeka F, Yang K. PMID: 24861874; PMCID: PMC4104812.
View in:
PubMed Mentions:
7 Fields:
-
Every 36-h gentamicin dosing in neonates with hypoxic-ischemic encephalopathy receiving hypothermia. J Perinatol. 2013 Oct; 33(10):778-82.
Frymoyer A, Lee S, Bonifacio SL, Meng L, Lucas SS, Guglielmo BJ, Sun Y, Verotta D. PMID: 23702622; PMCID: PMC3762884.
View in:
PubMed Mentions:
12 Fields:
Translation:
Humans
-
Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia. Pharmacotherapy. 2013 Jul; 33(7):718-26.
Frymoyer A, Meng L, Bonifacio SL, Verotta D, Guglielmo BJ. PMID: 23553582; PMCID: PMC3700641.
View in:
PubMed Mentions:
26 Fields:
Translation:
Humans
-
Population pharmacokinetics of unbound mycophenolic acid in adult allogeneic haematopoietic cell transplantation: effect of pharmacogenetic factors. Br J Clin Pharmacol. 2013 Feb; 75(2):463-75.
Frymoyer A, Verotta D, Jacobson P, Long-Boyle J. PMID: 22765258; PMCID: PMC3579261.
View in:
PubMed Mentions:
12 Fields:
Translation:
Humans
-
Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women. AIDS. 2012 Apr 24; 26(7):833-41.
Dong BJ, Zheng Y, Hughes MD, Frymoyer A, Verotta D, Lizak P, Sawe F, Currier JS, Lockman S, Aweeka FT, AIDS Clinical Trials Group Study 5208 Team. PMID: 22301417; PMCID: PMC3506024.
View in:
PubMed Mentions:
21 Fields:
Translation:
HumansCTClinical Trials
-
A method to quantify illicit intake of drugs from urine: methamphetamine. J Pharmacol Exp Ther. 2011 Jul; 338(1):31-6.
Li L, Galloway GP, Verotta D, Everhart ET, Baggott MJ, Coyle JR, Lopez JC, Mendelson J. PMID: 21450932; PMCID: PMC3126645.
View in:
PubMed Mentions: Fields:
Translation:
HumansPHPublic Health
-
Fractional dynamics pharmacokinetics-pharmacodynamic models. J Pharmacokinet Pharmacodyn. 2010 Jun; 37(3):257-76.
Verotta D. PMID: 20455076; PMCID: PMC2889283.
View in:
PubMed Mentions:
9 Fields:
-
Fractional compartmental models and multi-term Mittag-Leffler response functions. J Pharmacokinet Pharmacodyn. 2010 Apr; 37(2):209-15; discussion 217-20.
Verotta D. PMID: 20405313; PMCID: PMC2861176.
View in:
PubMed Mentions:
10 Fields:
-
Population analyses of atorvastatin clearance in patients living in the community and in nursing homes. Clin Pharmacol Ther. 2009 Nov; 86(5):497-502.
Schwartz JB, Verotta D. PMID: 19571802.
View in:
PubMed Mentions:
7 Fields:
Translation:
Humans
-
Oral heroin in opioid-dependent patients: pharmacokinetic comparison of immediate and extended release tablets. Eur J Pharm Sci. 2009 Mar 02; 36(4-5):421-32.
Perger L, Rentsch KM, Kullak-Ublick GA, Verotta D, Fattinger K. PMID: 19084595; PMCID: PMC2753514.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
A mechanistic model for the sex-specific response to nalbuphine and naloxone in postoperative pain. J Pharmacokinet Pharmacodyn. 2008 Feb; 35(1):69-83.
Kshirsagar S, Gear R, Levine J, Verotta D. PMID: 17943420.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Reversible jump Markov chain Monte Carlo for deconvolution. J Pharmacokinet Pharmacodyn. 2007 Jun; 34(3):263-87.
Kang D, Verotta D. PMID: 17221310.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Improving data reliability using a non-compliance detection method versus using pharmacokinetic criteria. J Pharmacokinet Pharmacodyn. 2007 Feb; 34(1):35-55.
Kshirsagar SA, Blaschke TF, Sheiner LB, Krygowski M, Acosta EP, Verotta D. PMID: 17004125.
View in:
PubMed Mentions:
3 Fields:
Translation:
HumansCells
-
A non-linear mixed effect dynamic model incorporating prior exposure and adherence to treatment to describe long-term therapy outcome in HIV-patients. J Pharmacokinet Pharmacodyn. 2006 Aug; 33(4):519-42.
Labbé L, Verotta D. PMID: 16786410.
View in:
PubMed Mentions:
9 Fields:
Translation:
HumansCells
-
Pharmacokinetic-pharmacodynamic modelling: history and perspectives. J Pharmacokinet Pharmacodyn. 2006 Jun; 33(3):227-79.
Csajka C, Verotta D. PMID: 16404503.
View in:
PubMed Mentions:
45 Fields:
Translation:
HumansCells
-
Population analyses of amlodipine in patients living in the community and patients living in nursing homes. Clin Pharmacol Ther. 2006 Jan; 79(1):114-24.
Kang D, Verotta D, Schwartz JB. PMID: 16413246.
View in:
PubMed Mentions:
5 Fields:
Translation:
Humans
-
Sample size computations for PK/PD population models. J Pharmacokinet Pharmacodyn. 2005 Dec; 32(5-6):685-701.
Kang D, Schwartz JB, Verotta D. PMID: 16284914.
View in:
PubMed Mentions:
14 Fields:
Translation:
Humans
-
The use of a sum of inverse Gaussian functions to describe the absorption profile of drugs exhibiting complex absorption. Pharm Res. 2005 Aug; 22(8):1227-35.
Csajka C, Drover D, Verotta D. PMID: 16078132.
View in:
PubMed Mentions:
20 Fields:
-
A predictive model for exemestane pharmacokinetics/pharmacodynamics incorporating the effect of food and formulation. Br J Clin Pharmacol. 2005 Mar; 59(3):355-64.
Valle M, Di Salle E, Jannuzzo MG, Poggesi I, Rocchetti M, Spinelli R, Verotta D. PMID: 15752382; PMCID: PMC1884784.
View in:
PubMed Mentions:
10 Fields:
Translation:
HumansCTClinical Trials
-
Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects. Br J Clin Pharmacol. 2005 Mar; 59(3):335-45.
Csajka C, Haller CA, Benowitz NL, Verotta D. PMID: 15752380; PMCID: PMC1884794.
View in:
PubMed Mentions:
10 Fields:
Translation:
Humans
-
Mechanistic pharmacokinetic and pharmacodynamic modeling of CHF3381 (2-[(2,3-dihydro-1H-inden-2-yl)amino]acetamide monohydrochloride), a novel N-methyl-D-aspartate antagonist and monoamine oxidase-A inhibitor in healthy subjects. J Pharmacol Exp Ther. 2005 May; 313(2):647-57.
Csajka C, Imbimbo BP, Piccinno A, Dostert P, Verotta D. PMID: 15671203.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
A sample size computation method for non-linear mixed effects models with applications to pharmacokinetics models. Stat Med. 2004 Aug 30; 23(16):2551-66.
Kang D, Schwartz JB, Verotta D. PMID: 15287084.
View in:
PubMed Mentions:
8 Fields:
Translation:
Humans
-
CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy. Brain. 2004 May; 127(Pt 5):1047-60.
Valle M, Price RW, Nilsson A, Heyes M, Verotta D. PMID: 15013955.
View in:
PubMed Mentions:
28 Fields:
Translation:
HumansCells
-
Volterra series in pharmacokinetics and pharmacodynamics. J Pharmacokinet Pharmacodyn. 2003 Oct; 30(5):337-62.
Verotta D. PMID: 14977164.
View in:
PubMed Mentions:
2 Fields:
-
Population analyses of sustained-release verapamil in patients: effects of sex, race, and smoking. Clin Pharmacol Ther. 2003 Jan; 73(1):31-40.
Kang D, Verotta D, Krecic-Shepard ME, Modi NB, Gupta SK, Schwartz JB. PMID: 12545141.
View in:
PubMed Mentions:
8 Fields:
Translation:
Humans
-
Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers. Anesthesiology. 2002 Oct; 97(4):827-36.
Drover DR, Angst MS, Valle M, Ramaswamy B, Naidu S, Stanski DR, Verotta D. PMID: 12357147.
View in:
PubMed Mentions:
27 Fields:
Translation:
HumansCTClinical Trials
-
Modeling nicotine arterial-venous differences to predict arterial concentrations and input based on venous measurements: application to smokeless tobacco and nicotine gum. J Pharmacokinet Pharmacodyn. 2002 Aug; 29(4):383-402.
Pitsiu M, Gries JM, Benowitz N, Gourlay SG, Verotta D. PMID: 12518710.
View in:
PubMed Mentions:
8 Fields:
Translation:
Humans
-
Non-linear dynamics models characterizing long-term virological data from AIDS clinical trials. Math Biosci. 2002 Apr; 176(2):163-83.
Verotta D, Schaedeli F. PMID: 11916507.
View in:
PubMed Mentions:
5 Fields:
Translation:
HumansCells
-
Influence of arterial vs. venous sampling site on nicotine tolerance model selection and parameter estimation. J Pharmacokinet Pharmacodyn. 2002 Feb; 29(1):49-66.
Schaedeli F, Pitsiu M, Benowitz NL, Gourlay SG, Verotta D. PMID: 12194535.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of possible noncompliance. J Pharmacokinet Pharmacodyn. 2001 Aug; 28(4):343-62.
Lu J, Gries JM, Verotta D, Sheiner LB. PMID: 11677931.
View in:
PubMed Mentions:
15 Fields:
Translation:
Humans
-
A semiparametric deconvolution model to establish in vivo-in vitro correlation applied to OROS oxybutynin. J Pharm Sci. 2001 Jun; 90(6):702-12.
Pitsiu M, Sathyan G, Gupta S, Verotta D. PMID: 11357173.
View in:
PubMed Mentions:
8 Fields:
Translation:
Humans
-
Linear mixed-effect multivariate adaptive regression splines applied to nonlinear pharmacokinetics data. J Biopharm Stat. 2000 Aug; 10(3):383-98.
Gries JM, Verotta D. PMID: 10959918.
View in:
PubMed Mentions:
2 Fields:
Translation:
Animals
-
Nasal mucosal versus gastrointestinal absorption of nasally administered cocaine. Eur J Clin Pharmacol. 2000 Jul; 56(4):305-10.
Fattinger K, Benowitz NL, Jones RT, Verotta D. PMID: 10954344.
View in:
PubMed Mentions:
10 Fields:
Translation:
HumansCTClinical Trials
-
Additive inhibition of nicotinic acetylcholine receptors by corticosteroids and the neuromuscular blocking drug vecuronium. Anesthesiology. 2000 Mar; 92(3):821-32.
Kindler CH, Verotta D, Gray AT, Gropper MA, Yost CS. PMID: 10719961.
View in:
PubMed Mentions:
8 Fields:
Translation:
HumansAnimalsCells
-
Down-regulation models and modeling of testosterone production induced by recombinant human choriogonadotropin. J Pharmacol Exp Ther. 1999 Apr; 289(1):371-7.
Gries JM, Munafo A, Porchet HC, Verotta D. PMID: 10087026.
View in:
PubMed Mentions:
6 Fields:
Translation:
HumansCells
-
A general solution for nonparametric control of a linear system using computer-controlled infusion pumps. IEEE Trans Biomed Eng. 1999 Jan; 46(1):44-50.
Verotta D. PMID: 9919825.
View in:
PubMed Mentions:
1 Fields:
Translation:
HumansAnimals
-
Characterizing the variability of system kernel and input estimates. Ann Biomed Eng. 1998 Sep-Oct; 26(5):870-82.
Verotta D. PMID: 9779960.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Use of a pharmacokinetic/pharmacodynamic model to design an optimal dose input profile. J Pharmacokinet Biopharm. 1998 Aug; 26(4):471-92.
Park K, Verotta D, Gupta SK, Sheiner LB. PMID: 10214563.
View in:
PubMed Mentions:
7 Fields:
Translation:
HumansCTClinical Trials
-
Importance of chronopharmacokinetics in design and evaluation of transdermal drug delivery systems. J Pharmacol Exp Ther. 1998 May; 285(2):457-63.
Gries JM, Benowitz N, Verotta D. PMID: 9580583.
View in:
PubMed Mentions:
7 Fields:
Translation:
Humans
-
Passive versus electrotransport-facilitated transdermal absorption of ketorolac. Clin Pharmacol Ther. 1998 Mar; 63(3):303-15.
Park K, Verotta D, Gupta SK, Sheiner LB. PMID: 9542474.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Exposure-response relationships for saquinavir, zidovudine, and zalcitabine in combination therapy. Antimicrob Agents Chemother. 1997 Nov; 41(11):2433-8.
Vanhove GF, Gries JM, Verotta D, Sheiner LB, Coombs R, Collier AC, Blaschke TF. PMID: 9371346; PMCID: PMC164141.
View in:
PubMed Mentions:
11 Fields:
Translation:
HumansCTClinical Trials
-
Age effects on interrelationships between lung volume and heart rate during standing. Am J Physiol. 1997 11; 273(5):H2128-34.
Stanley G, Verotta D, Craft N, Siegel RA, Schwartz JB. PMID: 9374744.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Pharmacokinetics of saquinavir, zidovudine, and zalcitabine in combination therapy. Antimicrob Agents Chemother. 1997 Nov; 41(11):2428-32.
Vanhove GF, Kastrissios H, Gries JM, Verotta D, Park K, Collier AC, Squires K, Sheiner LB, Blaschke TF. PMID: 9371345; PMCID: PMC164140.
View in:
PubMed Mentions:
9 Fields:
Translation:
HumansCTClinical Trials
-
A semiparametric method for describing noisy population pharmacokinetic data. J Pharmacokinet Biopharm. 1997 Oct; 25(5):615-42.
Park K, Verotta D, Blaschke TF, Sheiner LB. PMID: 9679225.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Pharmacodynamics of acute tolerance to multiple nicotinic effects in humans. J Pharmacol Exp Ther. 1997 Jun; 281(3):1238-46.
Fattinger K, Verotta D, Benowitz NL. PMID: 9190859.
View in:
PubMed Mentions:
15 Fields:
Translation:
HumansCTClinical Trials
-
A pooled analysis of CD4 response to zidovudine and zalcitabine treatment in patients with AIDS and AIDS-related complex. Clin Pharmacol Ther. 1997 Jan; 61(1):70-82.
Gries JM, Troconiz IF, Verotta D, Jacobson M, Sheiner LB. PMID: 9024175.
View in:
PubMed Mentions:
7 Fields:
Translation:
HumansCTClinical Trials
-
A general framework for non-parametric subject-specific and population deconvolution methods for in vivo-in vitro correlation. Adv Exp Med Biol. 1997; 423:43-52.
Verotta D. PMID: 9269482.
View in:
PubMed Mentions:
1 Fields:
Translation:
HumansCells
-
Chronopharmacokinetics of nicotine. Clin Pharmacol Ther. 1996 Oct; 60(4):385-95.
Gries JM, Benowitz N, Verotta D. PMID: 8873686.
View in:
PubMed Mentions:
14 Fields:
Translation:
HumansCTClinical Trials
-
Modeling a bivariate control system: LH and testosterone response to the GnRH antagonist antide. Am J Physiol. 1996 Oct; 271(4 Pt 1):E775-87.
Fattinger KE, Verotta D, Porchet HC, Munafo A, Le Cotonnec JY, Sheiner LB. PMID: 8897868.
View in:
PubMed Mentions:
13 Fields:
Translation:
HumansCellsCTClinical Trials
-
Age and autonomic effects on interrelationships between lung volume and heart rate. Am J Physiol. 1996 May; 270(5 Pt 2):H1833-40.
Stanley G, Verotta D, Craft N, Siegel RA, Schwartz JB. PMID: 8928893.
View in:
PubMed Mentions:
4 Fields:
Translation:
HumansCTClinical Trials
-
A descriptive tool to characterize nonlinear kinetics, with applications to meperidine and lidocaine. J Pharm Sci. 1996 Apr; 85(4):362-8.
Gries JM, Upton R, Huang YF, Verotta D. PMID: 8901069.
View in:
PubMed Mentions:
3 Fields:
Translation:
Animals
-
Concepts, properties, and applications of linear systems to describe distribution, identify input, and control endogenous substances and drugs in biological systems. Crit Rev Biomed Eng. 1996; 24(2-3):73-139.
Verotta D. PMID: 9108983.
View in:
PubMed Mentions:
19 Fields:
Translation:
Humans
-
A new method to explore the distribution of interindividual random effects in non-linear mixed effects models. Biometrics. 1995 Dec; 51(4):1236-51.
Fattinger KE, Sheiner LB, Verotta D. PMID: 8589220.
View in:
PubMed Mentions:
10 Fields:
Translation:
Humans
-
A nonparametric subject-specific population method for deconvolution: I. Description, internal validation, and real data examples. J Pharmacokinet Biopharm. 1995 Dec; 23(6):581-610.
Fattinger KE, Verotta D. PMID: 8733948.
View in:
PubMed Mentions:
12 Fields:
-
A nonparametric subject-specific population method for deconvolution: II. External validation. J Pharmacokinet Biopharm. 1995 Dec; 23(6):611-34.
Fattinger KE, Verotta D. PMID: 8733949.
View in:
PubMed Mentions:
8 Fields:
-
Estimating bioavailability when clearance changes in time: the effect of model misspecification. Clin Pharmacol Ther. 1995 Nov; 58(5):595-600.
Fattinger KE, Verotta D. PMID: 7586955.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Further notes on physiologic indirect response models. Clin Pharmacol Ther. 1995 Aug; 58(2):238-40.
Sheiner LB, Verotta D. PMID: 7648775.
View in:
PubMed Mentions:
6 Fields:
-
A general conceptual model for non-steady state pharmacokinetic/pharmacodynamic data. J Pharmacokinet Biopharm. 1995 Feb; 23(1):1-4.
Verotta D, Sheiner LB. PMID: 8576839.
View in:
PubMed Mentions:
17 Fields:
Translation:
HumansAnimals
-
Pharmacokinetic-pharmacodynamic (PK-PD) modelling in non-steady-state studies and arterio-venous drug concentration differences. Br J Clin Pharmacol. 1994 Nov; 38(5):389-400.
Gumbleton M, Oie S, Verotta D. PMID: 7893578; PMCID: PMC1364870.
View in:
PubMed Mentions:
6 Fields:
-
Semiparametric models for antagonistic drug interactions. J Appl Physiol (1985). 1994 May; 76(5):2224-33.
Troconiz IF, Sheiner LB, Verotta D. PMID: 7914889.
View in:
PubMed Mentions:
5 Fields:
Translation:
AnimalsCells
-
Estimation and model selection in constrained deconvolution. Ann Biomed Eng. 1993 Nov-Dec; 21(6):605-20.
Verotta D. PMID: 8116913.
View in:
PubMed Mentions:
12 Fields:
Translation:
HumansAnimals
-
Two constrained deconvolution methods using spline functions. J Pharmacokinet Biopharm. 1993 Oct; 21(5):609-36.
Verotta D. PMID: 8145134.
View in:
PubMed Mentions:
6 Fields:
Translation:
Humans
-
Aging effects on stereoselective pharmacokinetics and pharmacodynamics of verapamil. J Pharmacol Exp Ther. 1993 May; 265(2):690-8.
Schwartz JB, Troconiz IF, Verotta D, Liu S, Capili H. PMID: 8496816.
View in:
PubMed Mentions:
9 Fields:
Translation:
Humans
-
Elderly, conscious patients have an accentuated hypotensive response to nitroglycerin. Anesthesiology. 1992 Oct; 77(4):646-55.
Cahalan MK, Hashimoto Y, Aizawa K, Verotta D, Ionescu P, Balea M, Eger EI, Benet LZ, Ehrenfeld WK, Goldstone J, et al. PMID: 1416161.
View in:
PubMed Mentions:
5 Fields:
Translation:
HumansCTClinical Trials
-
Building population pharmacokinetic--pharmacodynamic models. I. Models for covariate effects. J Pharmacokinet Biopharm. 1992 Oct; 20(5):511-28.
Mandema JW, Verotta D, Sheiner LB. PMID: 1287200.
View in:
PubMed Mentions:
207 Fields:
Translation:
Humans
-
Comparing responses when each response is a curve. Am J Physiol. 1992 Jul; 263(1 Pt 2):R206-14.
Verotta D, Sheiner LB. PMID: 1636790.
View in:
PubMed Mentions:
1 Fields:
Translation:
HumansAnimals
-
Effects of interleukin 3 and interleukin 6 on platelet recovery in mice treated with 5-fluorouracil. Exp Hematol. 1992 May; 20(4):462-9.
Carrington PA, Hill RJ, Levin J, Verotta D. PMID: 1568463.
View in:
PubMed Mentions:
2 Fields:
Translation:
AnimalsCells
-
Semiparametric analysis of non-steady-state pharmacodynamic data. J Pharmacokinet Biopharm. 1991 Dec; 19(6):691-712.
Verotta D, Sheiner LB. PMID: 1815048.
View in:
PubMed Mentions:
10 Fields:
Translation:
Humans
-
Reversal of neuromuscular blockade in humans by neostigmine and edrophonium: a mathematical model. J Pharmacokinet Biopharm. 1991 Dec; 19(6):713-29.
Verotta D, Kitts J, Rodriguez R, Coldwell J, Miller RD, Sheiner LB. PMID: 1687690.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Mean time parameters for generalized physiological flow models (semihomogeneous linear systems). J Pharmacokinet Biopharm. 1991 Jun; 19(3):319-31.
Verotta D, Sheiner LB, Beal SL. PMID: 1875285.
View in:
PubMed Mentions:
3 Fields:
-
An application of the D-optimal criterion to define the experimental design for a particular class of semi-parametric models. Comput Methods Programs Biomed. 1990 Nov; 33(3):181-7.
Verotta D. PMID: 2279391.
View in:
PubMed Mentions: Fields:
Translation:
Animals
-
Comments on two recent deconvolution methods. J Pharmacokinet Biopharm. 1990 Oct; 18(5):483-9; discussion 489-99.
Verotta D. PMID: 2266499.
View in:
PubMed Mentions:
5 Fields:
-
Comparative tissue concentration profiles of fentanyl and alfentanil in humans predicted from tissue/blood partition data obtained in rats. Anesthesiology. 1990 May; 72(5):865-73.
Björkman S, Stanski DR, Verotta D, Harashima H. PMID: 2339802.
View in:
PubMed Mentions:
16 Fields:
Translation:
HumansAnimals
-
Pharmacodynamic modeling of verapamil effects under steady-state and nonsteady-state conditions. J Pharmacol Exp Ther. 1989 Dec; 251(3):1032-8.
Schwartz JB, Verotta D, Sheiner LB. PMID: 2600802.
View in:
PubMed Mentions:
11 Fields:
Translation:
Humans
-
The pharmacokinetics and pharmacodynamics of diltiazem and its metabolites in healthy adults after a single oral dose. Clin Pharmacol Ther. 1989 Oct; 46(4):408-19.
Boyd RA, Chin SK, Don-Pedro O, Verotta D, Sheiner LB, Williams RL, Giacomini KM. PMID: 2791444.
View in:
PubMed Mentions:
17 Fields:
Translation:
HumansCells
-
A semiparametric approach to physiological flow models. J Pharmacokinet Biopharm. 1989 Aug; 17(4):463-91.
Verotta D, Sheiner LB, Ebling WF, Stanski DR. PMID: 2614682.
View in:
PubMed Mentions:
12 Fields:
-
An inequality-constrained least-squares deconvolution method. J Pharmacokinet Biopharm. 1989 Apr; 17(2):269-89.
Verotta D. PMID: 2677315.
View in:
PubMed Mentions:
16 Fields:
-
Pharmacokinetic and pharmacodynamic modelling of metoprolol in rabbits with liver failure. Eur J Drug Metab Pharmacokinet. 1989 Apr-Jun; 14(2):145-51.
Bortolotti A, Castelli D, Verotta D, Bonati M. PMID: 2591419.
View in:
PubMed Mentions:
1 Fields:
Translation:
AnimalsCells
-
Semiparametric approach to pharmacokinetic-pharmacodynamic data. Am J Physiol. 1989 Apr; 256(4 Pt 2):R1005-10.
Verotta D, Beal SL, Sheiner LB. PMID: 2705568.
View in:
PubMed Mentions:
24 Fields:
Translation:
Humans
-
A new criterion for selection of pharmacokinetic multiexponential equations. J Pharm Sci. 1988 Sep; 77(9):784-9.
Imbimbo BP, Imbimbo E, Daniotti S, Verotta D, Bassotti G. PMID: 2976092.
View in:
PubMed Mentions:
20 Fields:
Translation:
Humans
-
Software for experimental design: the computer program EXCAD. Comput Methods Programs Biomed. 1988 Mar-Apr; 26(2):159-66.
Verotta D. PMID: 3359766.
View in:
PubMed Mentions: Fields:
-
D-optimal design applied to binding saturation curves of an enkephalin analog in rat brain. Life Sci. 1988; 42(6):735-43.
Verotta D, Petrillo P, La Regina A, Rocchetti M, Tavani A. PMID: 2828802.
View in:
PubMed Mentions:
1 Fields:
Translation:
Animals
-
Simultaneous modeling of pharmacokinetics and pharmacodynamics: an improved algorithm. Comput Appl Biosci. 1987 Nov; 3(4):345-9.
Verotta D, Sheiner LB. PMID: 2898970.
View in:
PubMed Mentions:
16 Fields:
Translation:
Humans
-
Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man. J Pharmacokinet Biopharm. 1987 Jun; 15(3):241-53.
Schüttler J, Stanski DR, White PF, Trevor AJ, Horai Y, Verotta D, Sheiner LB. PMID: 3668802.
View in:
PubMed Mentions:
34 Fields:
Translation:
Humans
-
Differential postnatal development of mu-, delta- and kappa-opioid binding sites in rat brain. Brain Res. 1987 Jan; 428(1):53-8.
Petrillo P, Tavani A, Verotta D, Robson LE, Kosterlitz HW. PMID: 3815117.
View in:
PubMed Mentions:
12 Fields:
Translation:
AnimalsCells
-
MODDIS: a microcomputer program for model discrimination. Comput Methods Programs Biomed. 1986 Apr; 22(2):209-18.
Verotta D, Recchia M, Urso R. PMID: 3635460.
View in:
PubMed Mentions: Fields:
-
Non-linear fitting program for biological data. Int J Biomed Comput. 1986 Jan; 18(1):25-8.
Bartosek I, Verotta D. PMID: 3753954.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Allosteric inhibition as a model to explain flatter displacement curves in binding experiments: application to "heterogeneous" serotonin receptors. J Recept Res. 1986; 6(1):27-46.
Gobbi M, Barone D, Dagnino G, Verotta D, Mennini T. PMID: 3712356.
View in:
PubMed Mentions: Fields:
Translation:
AnimalsCells